As part of its consolidation strategy in the medical devices sector, Dislog Group has announced a MAD 140 million financing round with CDG Invest Growth, via the Capmezzanine III fund.
This strategic investment will enable Dislog Dispositifs Médicaux (DDM) to pursue its growth, combining organic development and external growth to strengthen its position in Morocco and internationally. DDM thus becomes the consolidation structure for the Group's future acquisitions in this key sector, notably Megaflex, Africare, Afrobiomedic and Farmalac.
Moncef Belkhayat, President of Dislog Group:
"Our aim is to build a benchmark player in medical devices, with a broad offering, serving both the public and private sectors, in Morocco and then in Africa."
Hassan Laaziri, Managing Director of CDG Invest Growth:
"We are delighted to support Dislog Group in this ambition. This fifth transaction in the healthcare sector reflects our confidence in this industry and our commitment to contributing to its development."
This operation marks a new stage in the Dislog Group's mission to facilitate access to high-quality medical technologies and support national health sovereignty.